Titusville, NJ, United States of America

Lawrence J Kennedy

This inventor holds 16 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in LPA Antagonists. Top assignees: Bristol-Myers Squibb Compnay, Syngene International Limited. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence J Kennedy. Retrieved from https://idiyas.com/inventor/lawrence-j-kennedy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 8.9

ph-index = 5

Forward Citations = 113(Granted Patents)

Company Filing History:

16 out of 3,746

Bristol-Myers Squibb Compnay

patents

1 out of 7

Syngene International Limited

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

LPA Antagonists

Triazole Compounds

Carbamoyl Acids

Cyclohexyl Acids

Bicyclic Nitrogen

Heteroaryl Modulators

11-Beta Hydroxysteroid

Dehydrogenase Inhibitors

Titusville, NJ

Pyrazole Compounds

Substituted Triazoles

Triazine Compounds

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195444 - Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists (2025-01-14),

2. 11697646 - Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists (2023-07-11),

3. RE49352 - Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists (2023-01-02),

4. 11319315 - Cyclohexyl acid triazole azoles as LPA antagonists (2022-05-03),

5. 11267800 - Cyclohexyl acid triazole azines as LPA antagonists (2022-03-08),

6. 11261174 - Pyrazole O-linked carbamoyl cyclohexyl acids as LPA antagonists (2022-03-01),

7. 11008300 - Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists (2021-05-18),

8. 11007180 - Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists (2021-05-18),

9. 10662172 - Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists (2020-05-26),

10. 10576062 - Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists (2020-03-03),

11. 10071078 - Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists (2018-09-11),

12. 9062028 - Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators (2015-06-23),

13. 8546394 - Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors (2013-10-01),

14. 8541444 - Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors (2013-09-24),

15. 8119658 - Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors (2012-02-21),

Title: The Inventor Lawrence J Kennedy: Pioneering Innovations in Titusville, NJ

Introduction: Lawrence J Kennedy is a distinguished inventor based in Titusville, NJ, known for his groundbreaking contributions to various fields.

Latest Patents: Lawrence J Kennedy holds several patents in the areas of renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: With a career spanning over two decades, Lawrence J Kennedy has worked tirelessly to develop cutting-edge solutions that have positively impacted industries worldwide.

Collaborations: Throughout his career, Lawrence J Kennedy has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life.

Conclusion: Lawrence J Kennedy's passion for innovation and his dedication to creating a better future through his inventions make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.